Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
15
NCT02016833
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
Phase: N/A
Role: Lead Sponsor
Start: Oct 31, 2013
Completion: Dec 31, 2014